Similar drugsTo uncover
Dosage form: & nbspointment for external use
Composition:

1 g of ointment contains:

active substances: hydrocortisone acetate - 4,0 mg, sulfur (sulfur precipitated, sulfur ground) - 100.0 mg;

Excipients: Vaseline (petroleum jelly) - 450,0 mg, lanolin (lanolin anhydrous) - 100,0 mg, stearic acid - 30,0 mg, pentaerythritol dioleate (pentol) - 50,0 mg, methylparahydroxybenzoate (nipagin) - 0,8 mg, propyl parahydroxybenzoate (nipazole) 0.2 mg, water (purified water) up to 1 g.
Description:

Ointment is light yellow with a grayish tinge.

Pharmacotherapeutic group:glucocorticosteroid for topical use + antimicrobial agent
ATX: & nbsp
  • Hydrocortisone in combination with antiseptics
  • Pharmacodynamics:

    Sulfadecortem ® ointment has a specific for its active substances - hydrocortisone and sulfur - anti-inflammatory, anti-exudative, exfoliating, antipruritic, keratolytic and epidermoplastic action.

    Sulfur is an antiseptic, fungicidal, keratolytic, epidermoplastic agent. Sulfur when applied to the skin, interacting with organic substances, forms sulphides and pentathionic acid, which have an antimicrobial and antiparasitic effect. Sulfides possess keratoplastic properties.

    Hydrocortisone - synthetic non-halogenated steroid, belongs to the first class (weakly active) glucocorticosteroid agents (SCS).

    Hydrocortisone has anti-inflammatory, anti-allergic, antipruritic and desensitizing effects. Pharmacological effects of hydrocortisone are realized due to hyposensitization of the receptors of the affected skin to histamine and serotonin, blockade of histamine A2, increased activity of hyaluronidase, which is associated with a decrease in permeability of the vascular wall, exudative phenomena and itching, normalization of vascular tone and stabilization of cell membranes.

    The anti-inflammatory effect of hydrocortisone is also associated with the inhibitory effect on the synthesis of mediators of inflammation (prostaglandins, leukotrienes, interleukins, complement components, etc.).

    Showing high therapeutic activity at any stage of inflammation, SCS quickly suppresses the symptoms of dermatoses, suppressing the main links of both early and late phases of inflammation.

    The overall superior effect of the combination of sulfur with hydrocortisone is interdependent: sulfur strengthens the effects of hydrocortisone; hydrocortisone, somewhat restraining, optimizes the keratolytic action of sulfur, prevents the development of its side effects, prevents its irritating effect.

    Pharmacokinetics:

    The pharmacokinetics of this two-component preparation has not been studied.

    Indications:

    Seborrheic dermatitis, psoriasis.

    Contraindications:

    Hypersensitivity to the drug components, postvaccinal period, bacterial, viral, fungal skin diseases, skin tuberculosis, breach of the integrity of the skin (ulcers, wounds), syphilitic skin lesions, skin tumors, vulgar acne, perioral dermatitis.

    Carefully:

    Pregnancy, lactation, diabetes, tuberculosis (systemic lesion), children under 12 years.

    Pregnancy and lactation:

    Use of Sulfadecorthem® Ointments during Pregnancy (I, II, III trimesters) and during the lactation period is not contraindicated.

    Glucocorticosteroids penetrate the placental barrier. Effects on the fetus can be particularly pronounced when applying the drug to large areas of damage.

    There is no data on the amount of hydrocortisone excreted in breast milk.When prescribing the drug during lactation, it is recommended that special care be taken.

    If prolonged use is necessary in large areas, you should consult your doctor to resolve the issue of stopping breastfeeding.

    Dosing and Administration:

    Outwardly.

    A small amount of the drug with light massaging movements is applied to the affected skin 2 times a day. As soon as the effect is achieved, the drug is applied 1-3 times a week. The course of treatment is 1-3 weeks.

    In the refractory course of the disease, the occlusion dressing can be applied.

    With psoriasis of the scalp, the drug is applied to the skin after washing the head with a neutral remedy.

    The dose of the drug used during the week should not exceed 30-60 g.
    Side effects:

    Allergic contact dermatitis, itching, burning, irritation.

    If the dosing regimen and the course of therapy are disturbed (prolonged use and / or application to large areas), systemic adverse reactions of the GCS may develop.

    The risk of local and systemic adverse reactions increases with the use of an occlusive dressing.

    Overdose:

    Symptoms: development of systemic adverse reactions of glucocorticosteroids, such as oppression of the hypothalamic-pituitary-adrenal system, Itenko-Cushing syndrome, and local adverse reactions such as perioral dermatitis, skin atrophy, striae.

    Treatment: cessation of the use of glucocorticosteroids.
    Interaction:

    Data on the interaction of the ointment Sulfodecortam® (as well as the components of the drug) for external use with other drugs are not available.

    Special instructions:

    Do not use on large areas.

    Do not apply to the skin in the eye area.

    Use in children under 2 years - strictly according to the doctor's prescription.

    With persisting symptoms on the background of treatment, it is necessary to consult a doctor.

    Effect on the ability to drive transp. cf. and fur:

    Does not affect.

    Form release / dosage:Ointment for external use.
    Packaging:

    25 grams of aluminum tubes or polyethylene laminated tubes.

    Each tube, together with instructions for the medical use of the drug, is placed in a pack of cardboard.

    Storage conditions:

    Store at a temperature not exceeding 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years.

    Do not use the product after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:P N000401 / 01
    Date of registration:20.09.2011
    The owner of the registration certificate:Nizhny Novgorod Chemical and Pharmaceutical Plant, OJSCNizhny Novgorod Chemical and Pharmaceutical Plant, OJSC
    Manufacturer: & nbsp
    Representation: & nbspNizhpharm, JSCNizhpharm, JSCRussia
    Information update date: & nbsp03.03.2016
    Illustrated instructions
      Instructions
      Up